Evaluating muscle loss in patients with psoriatic arthritis
Evaluation of Sarcopenia and Related Factors in Patients Diagnosed With Psoriatic Arthritis
This study is trying to see how common muscle loss is in people with psoriatic arthritis compared to healthy individuals and how it affects their overall health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 102 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Ankara City Hospital Bilkent Academic / other |
| Locations | 1 site (Ankara, Bilkent-Cankaya) |
| Trial ID | NCT06437392 on ClinicalTrials.gov |
What this trial studies
This study aims to identify the prevalence of sarcopenia, or muscle loss, and its associated factors in patients diagnosed with psoriatic arthritis. Participants will be divided into two groups: those with psoriatic arthritis and healthy volunteers. The study will involve rheumatological examinations and the measurement of quadriceps muscle thickness using ultrasonography to assess muscle health. The goal is to better understand how sarcopenia affects this patient population and to explore the utility of ultrasound in diagnosing the condition.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 65 who have been diagnosed with psoriatic arthritis for at least one year.
Not a fit: Patients with neurological diseases, joint deformities, or cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved screening and management strategies for sarcopenia in patients with psoriatic arthritis.
How similar studies have performed: While there is ongoing research into sarcopenia in various populations, this specific approach using ultrasonography in psoriatic arthritis is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with psoriatic arthritis according to CASPAR criteria at least 1 year ago * Between 18 and 65 years old * Normal cognitive functions * Agrees to participate in the study * No changes in medical treatment for psoriatic arthritis in the last 3 months Exclusion Criteria: * Those with neurological diseases * Those with hip dysplasia * Those with upper and lower extremity deformities * Those with upper and lower extremity joint arthroplasty * Those with arthritis and deformities in the hands * Those with lumbar stabilization * Those with cognitive impairment preventing participation in the study * Those with body weight beyond the device\'s measurement capacity * Those who do not agree to participate in the study
Where this trial is running
Ankara, Bilkent-Cankaya
- Ankara Bilkent City Hospital Physical Therapy an Rehabilitation Hospital — Ankara, Bilkent-Cankaya, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Gonca Canan Dogan Tosun, Medical Doctor — Ankara City Hospital Bilkent
- Study coordinator: Tuba Güler, Assoc Prof
- Email: tubakulu@yahoo.com
- Phone: +905052841036
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.